Dr Mole has extensive experience with the design, development, manufacture and regulatory approval of biotechnology products in a number of territories, including SE Asia, having previously taken four products from the research bench to the market. Initially his interest was in the medical sector, but since 2007 has focused on animal health applications and has worked in a variety of projects with Moredun Research Institute, Roslin Foundation and the Institute for Animal Health. During this time he established Inocul8, a company focused on the development of novel veterinary vaccines, which assisted creating Wormvax Australia which produces the first commercially available vaccine (Barbervax) against gastro-intestinal nematodes infections in livestock. Dr Mole is a Business Development Manager within the Moredun Group, Project Manager for the EU funded Paragone project and Fund Manager for the Genomia Seed Fund. His key responsibilities focus on the translation of the Institutes intellectual property in to commercial outputs (such as vaccines) and fostering interactions with commercial collaborators. In addition he is responsible for the management and administration of the Institute’s Grant and Patent estates.